Pharmacotherapeutic Monitoring and Drug‐Related Problems in a Group of Patients From Colombia: Cross‐Sectional Study, 2023–2024

PURPOSE: A pharmacotherapeutic follow-up service is attended by pharmacists who systematically identify drug-related problems and work to resolve their associated negative outcomes. The aim was to describe the characteristics of a pharmacotherapeutic follow-up service and the factors associated with the presentation of drug-related problems in a group of patients affiliated to the Colombian Health System. METHODS: This was a cross-sectional study of patients who attended a DADER method-based pharmacotherapeutic follow-up service. The drug-related problems and their associated negative outcomes as well as the interventions performed on the patients were identified. Descriptive analysis and binary logistic regression were performed considering the presence of drug-related problems as a dependent variable (p < 0.05). RESULTS: A total of 18 563 patients were identified, with an average age of 64.8 ± 14.9 years, and 66.3% were women. The most common chronic diseases were hypertension (54.3%), diabetes mellitus (29.2%), and rheumatoid arthritis (25.9%). The average number of medications/patient was 5.0 ± 4.1. Drug-related problems were documented for 60.8% of the patients (1.6 drug-related problems/patient), mainly due to drug-drug interactions (25.4%). Negative outcomes associated with medication use were observed for 60.0% of the patients (42.0% predominantly related to safety). The most common intervention was patient education (50.9%), and the negative outcomes associated with Medication use were resolved for 31.1% of patients who had two or more consultations. Patients over 65 years of age (OR:1.20; 95% CI:1.06-1.36), those from Bogotá-Cundinamarca (OR:1.62; 95% CI:1.52-1.73), those treated with ≥ 10 drugs (OR:1.21; 95% CI:1.07-1.36) and those treated with anticoagulants (OR:1.91; 95% CI:1.70-2.14) were more likely to experience drug-related problems. CONCLUSIONS: Drug-related problems were frequently identified, with drug-drug interactions being the most prevalent problem. Drug-related problems were associated with increased age, an increased number of prescribed medications and the use of anticoagulants. Safety-related negative outcomes associated with medication use were common, education was the predominant intervention, and one-third of the negative outcomes associated with medication use were resolved.

Authors

Institutions

Publication Details

Journal
Pharmacoepidemiology and Drug Safety
Published
2026-04-01
DOI
https://doi.org/10.1002/pds.70366
Primary Topic
Pharmaceutical Practices and Patient Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pharmacotherapeutic Monitoring and Drug‐Related Problems in a Group of Patients From Colombia: Cross‐Sectional Study, 2023–2024

Jorge Enrique Machado‐Alba, Andrés Gaviria‐Mendoza, John Alexander López-Rincón, Luis Fernando Valladales‐Restrepo et al.
Pharmacoepidemiology and Drug Safety
Pharmaceutical Practices and Patient Outcomes
article

Pharmacotherapeutic Monitoring and Drug‐Related Problems in a Group of Patients From Colombia: Cross‐Sectional Study, 2023–2024

Jorge Enrique Machado‐Alba, Andrés Gaviria‐Mendoza, John Alexander López-Rincón, Luis Fernando Valladales‐Restrepo, Ana Camila Delgado-Araujo, Manuel Enrique Machado‐Duque, María Camila Oyuela-Gutiérrez, María Fernanda Hernández‐Giraldo, Juan Pablo Albanes‐Beltran
article en

Abstract

PURPOSE: A pharmacotherapeutic follow-up service is attended by pharmacists who systematically identify drug-related problems and work to resolve their associated negative outcomes. The aim was to describe the characteristics of a pharmacotherapeutic follow-up service and the factors associated with the presentation of drug-related problems in a group of patients affiliated to the Colombian Health System. METHODS: This was a cross-sectional study of patients who attended a DADER method-based pharmacotherapeutic follow-up service. The drug-related problems and their associated negative outcomes as well as the interventions performed on the patients were identified. Descriptive analysis and binary logistic regression were performed considering the presence of drug-related problems as a dependent variable (p < 0.05). RESULTS: A total of 18 563 patients were identified, with an average age of 64.8 ± 14.9 years, and 66.3% were women. The most common chronic diseases were hypertension (54.3%), diabetes mellitus (29.2%), and rheumatoid arthritis (25.9%). The average number of medications/patient was 5.0 ± 4.1. Drug-related problems were documented for 60.8% of the patients (1.6 drug-related problems/patient), mainly due to drug-drug interactions (25.4%). Negative outcomes associated with medication use were observed for 60.0% of the patients (42.0% predominantly related to safety). The most common intervention was patient education (50.9%), and the negative outcomes associated with Medication use were resolved for 31.1% of patients who had two or more consultations. Patients over 65 years of age (OR:1.20; 95% CI:1.06-1.36), those from Bogotá-Cundinamarca (OR:1.62; 95% CI:1.52-1.73), those treated with ≥ 10 drugs (OR:1.21; 95% CI:1.07-1.36) and those treated with anticoagulants (OR:1.91; 95% CI:1.70-2.14) were more likely to experience drug-related problems. CONCLUSIONS: Drug-related problems were frequently identified, with drug-drug interactions being the most prevalent problem. Drug-related problems were associated with increased age, an increased number of prescribed medications and the use of anticoagulants. Safety-related negative outcomes associated with medication use were common, education was the predominant intervention, and one-third of the negative outcomes associated with medication use were resolved.

Pharmacoepidemiology and Drug SafetyVol. 35(4)
Technological University of Pereira (CO), Institución Universitaria Visión de las Américas (CO)
Good health and well-being
Openalex Percentile: Top 25%
Pharmaceutical Practices and Patient Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.